$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
达沙替尼的副作用如何缓解
2025-10-19 11:44:20
Check Details
达沙替尼的副作用与注意事项
2025-10-19 11:44:20
Check Details
达沙替尼的用法用量
2025-10-19 11:44:20
Check Details
达沙替尼的适应症
2025-10-19 11:44:20
Check Details
米哚妥林的副作用如何缓解
2025-10-19 11:44:20
Check Details
米哚妥林的副作用与注意事项
2025-10-19 11:44:20
Check Details
米哚妥林的用药指南
2025-10-19 11:44:20
Check Details
米哚妥林的适应症
2025-10-19 11:44:20
Check Details
他米巴罗汀的副作用如何缓解
2025-10-19 11:44:20
Check Details
他米巴罗汀的副作用与注意事项
2025-10-19 11:44:20
Check Details
他米巴罗汀说明书,医保,价格,疗效,副作用
2025-10-19 11:44:20
Check Details
他米巴罗汀的用药指南
2025-10-19 11:44:20
Check Details
1
2
...
5049
5050
5051
5052
5053
5054
5055
...
10241
10242
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
2
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
3
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
4
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
5
Daraxonrasib Pregnancy, Lactation and Contraception Safety
6
Afatinib Side Effects and Safety Management
7
Capmatinib for MET Exon 14 Non-Small Cell Lung Cancer
8
Ibrutinib for CLL/SLL: Not for Immediate Use at Diagnosis
9
Key points for drug monitoring of Molotinib in bone marrow fibrosis
10
Elacestrant US Approval and Treatment Planning While Not Yet Available Locally
11
Stiripentol in Dravet Syndrome: Growth, Cognitive Development and Long-Term Follow-Up Management
12
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor: Mechanism, Dosing and MANEUVER Data